Cargando…
Factor VIII-Fc Activates Natural Killer Cells via Fc-Mediated Interactions With CD16
The most challenging complication associated with Factor VIII (FVIII) replacement therapy is the development of neutralizing anti-drug antibodies, or inhibitors, which occur in 23-35% of severe (FVIII level <1%) hemophilia A (HA) patients and are a serious hindrance to effective management of HA....
Autores principales: | Lagassé, H.A. Daniel, Hopkins, Louis B., Jankowski, Wojciech, Jacquemin, Marc G., Sauna, Zuben E., Golding, Basil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273617/ https://www.ncbi.nlm.nih.gov/pubmed/34262568 http://dx.doi.org/10.3389/fimmu.2021.692157 |
Ejemplares similares
-
Recombinant Factor VIII Fc Inhibits B Cell Activation via Engagement of the FcγRIIB Receptor
por: Georgescu, Maria T., et al.
Publicado: (2020) -
A structural homology approach to identify potential cross-reactive antibody responses following SARS-CoV-2 infection
por: McGill, Joseph R., et al.
Publicado: (2022) -
Impact of SARS-CoV-2 vaccination on FcγRIIIA/CD16 dynamics in Natural Killer cells: relevance for antibody-dependent functions
por: Capuano, Cristina, et al.
Publicado: (2023) -
Lack of FcRn Impairs Natural Killer Cell Development and Functions in the Tumor Microenvironment
por: Castaneda, Diana Cadena, et al.
Publicado: (2018) -
Fcγ receptor binding is required for maximal immunostimulation by CD70-Fc
por: Dadas, Osman, et al.
Publicado: (2023)